EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Core proteome mediated subtractive approach for the identification of potential therapeutic drug target against the honeybee pathogen Paenibacillus larvae

Sawsen Rebhi, Zarrin Basharat, Calvin R Wei, Salim Lebbal, Hanen Najjaa, Najla Sadfi-Zouaoui, Abdelmonaem Messaoudi

PeerJ · 27.05.2024 · 12 · e17292

DOI: 10.7717/peerj.17292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 27.05.2024. Verfasst von Sawsen Rebhi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Université de Tunis-El Manar, Laboratoire de Mycologie, Pathologies et Biomarqueurs, Département de Biologie, Tunis, Tunisia. Hauptthemen laut MEDLINE: Paenibacillus larvae, Proteome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education and Scientific Research of Tunisia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Objectives American foulbrood (AFB), caused by the highly virulent, spore-forming bacterium Paenibacillus larvae , poses a significant threat to honey bee brood. The widespread use of antibiotics not only fails to effectively combat the disease but also raises concerns regarding honey safety. The current computational study was attempted to identify a novel therapeutic drug target against P. larvae , a causative agent of American foulbrood disease in honey bee.

Methods

We investigated effective novel drug targets through a comprehensive in silico pan-proteome and hierarchal subtractive sequence analysis. In total, 14 strains of P. larvae genomes were used to identify core genes. Subsequently, the core proteome was systematically narrowed down to a single protein predicted as the potential drug target. Alphafold software was then employed to predict the 3D structure of the potential drug target. Structural docking was carried out between a library of phytochemicals derived from traditional Chinese flora ( n > 36,000) and the potential receptor using Autodock tool 1.5.6. Finally, molecular dynamics (MD) simulation study was conducted using GROMACS to assess the stability of the best-docked ligand.

Results

Proteome mining led to the identification of Ketoacyl-ACP synthase III as a highly promising therapeutic target, making it a prime candidate for inhibitor screening. The subsequent virtual screening and MD simulation analyses further affirmed the selection of ZINC95910054 as a potent inhibitor, with the lowest binding energy. This finding presents significant promise in the battle against P. larvae.

Conclusions

Computer aided drug design provides a novel approach for managing American foulbrood in honey bee populations, potentially mitigating its detrimental effects on both bee colonies and the honey industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paenibacillus larvaeProteomeAnimalsBeesAnti-Bacterial AgentsMolecular Docking SimulationMolecular Dynamics SimulationBacterial Proteins

Stichwörter der Autor:innen

American FoulbroodComputational drug designKetoacyl-ACP synthase IIIPaenibacillus larvae

Substanzen

ProteomeAnti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Université de Tunis-El Manar, Laboratoire de Mycologie, Pathologies et Biomarqueurs, Département de Biologie, Tunis, Tunisia.
  • Independent researcher, Islamabad, Pakistan.
  • Department of Research and Development, Shing Huei Group, Taipei, Taiwan.
  • University of Khenchela, Department of Agricultural Sciences, Faculty of Nature and Life Sciences, Khenchela, Algeria.
  • University of Gabes, Laboratory of Pastoral Ecosystem and Valorization of Spontaneous Plants and Associated Microorganisms, Institute of Arid Lands of Medenine, Medenine, Tunisia.
  • Jendouba University, Higher Institute of Biotechnology of Beja, Beja, Tunisia.

Förderung

  • Ministry of Higher Education and Scientific Research of Tunisia

Zitieren

APA

Rebhi, S., Basharat, Z., Wei, C. R., Lebbal, S., Najjaa, H., Sadfi-Zouaoui, N., & Messaoudi, A. (2024). Core proteome mediated subtractive approach for the identification of potential therapeutic drug target against the honeybee pathogen Paenibacillus larvae. PeerJ, 12, e17292. https://doi.org/10.7717/peerj.17292

Vancouver

Rebhi S, Basharat Z, Wei CR, Lebbal S, Najjaa H, Sadfi-Zouaoui N, et al. Core proteome mediated subtractive approach for the identification of potential therapeutic drug target against the honeybee pathogen Paenibacillus larvae. PeerJ. 2024;12:e17292. doi:10.7717/peerj.17292

BibTeX
@article{Rebhi2024,
  author = {Rebhi, Sawsen and Basharat, Zarrin and Wei, Calvin R and Lebbal, Salim and Najjaa, Hanen and Sadfi-Zouaoui, Najla and Messaoudi, Abdelmonaem},
  title = {Core proteome mediated subtractive approach for the identification of potential therapeutic drug target against the honeybee pathogen Paenibacillus larvae},
  journal = {PeerJ},
  year = {2024},
  volume = {12},
  pages = {e17292},
  doi = {10.7717/peerj.17292}
}
Kostenlos starten →